Cubist Systematic Strategies’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-81,220
Closed -$2.68M – 2997
2024
Q1
$2.68M Buy
81,220
+72,721
+856% +$2.27M 0.02% 1416
2023
Q4
$231K Buy
+8,499
New +$211K ﹤0.01% 2924
2023
Q3
– Sell
-9,909
Closed -$316K – 3347
2023
Q2
$316K Sell
9,909
-5,835
-37% -$189K ﹤0.01% 2611
2023
Q1
$482K Sell
15,744
-31,935
-67% -$1.26M ﹤0.01% 2686
2022
Q4
$1.86M Sell
47,679
-29,423
-38% -$1.32M 0.01% 1912
2022
Q3
$3.67M Sell
77,102
-127,353
-62% -$7.26M 0.02% 1376
2022
Q2
$7.91M Buy
204,455
+105,515
+107% +$4.19M 0.05% 615
2022
Q1
$5.67M Buy
98,940
+94,152
+1,966% +$6.18M 0.05% 622
2021
Q4
$382K Sell
4,788
-16,867
-78% -$1.44M ﹤0.01% 2637
2021
Q3
$1.88M Buy
+21,655
New +$2.18M 0.02% 1061
2021
Q2
– Sell
-16,953
Closed -$1.36M – 2923
2021
Q1
$1.36M Buy
+16,953
New +$1.61M 0.02% 1317
2020
Q4
– Sell
-600
Closed -$15K – 2558
2020
Q3
$15K Buy
600
+200
+50% +$4.96K ﹤0.01% 2417
2020
Q2
$11K Buy
+400
New +$8.62K ﹤0.01% 2338

Other funds holding BEAM

Cubist Systematic Strategies's BEAM Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 81,220 shares — an estimated $2.68M sold.

Cubist Systematic Strategies first reported a position in BEAM in Q2 2020 and held it in 13 quarters. The position peaked at $7.91M in Q2 2022. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 81,220 Beam Therapeutics shares in Q2 2024, an estimated $2.68M.
  • Cubist Systematic Strategies first reported a position in Beam Therapeutics in Q2 2020 and held it in 13 quarters.
  • Cubist Systematic Strategies's Beam Therapeutics position peaked at $7.91M in Q2 2022.
  • 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.